![Breast Cancer Clinical Research](https://www.precisionformedicine.com/hs-fs/hubfs/PFM%20-%202024%20New%20blog%20images/Breast-Cancer-Trends-Citeline-Data-Jan-2017-Oct-2022-1-662x372.jpg?width=396&height=224&name=Breast-Cancer-Trends-Citeline-Data-Jan-2017-Oct-2022-1-662x372.jpg)
![Andy, Kinley Avatar](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/Headshots/Headshots%20no%20background/AndyKinley_headshot.png?width=100&height=100&name=AndyKinley_headshot.png)
Andy Kinley
Andy Kinley, Ph.D. is Vice President of Innovation and Clinical Science at Precision for Medicine. He is a clinical researcher with over 25 years of combined experience leading basic and clinical research in oncology and hematology. His early scientific career focused on cancer cell signaling, setting a foundation to complement his clinical research roles in trial design and implementation of effective strategies for oncology clinical trials. Andy specializes in immuno-oncology trials (checkpoint inhibitors, T-cell agonists, bispecifics, cytokines, oncolytic viruses, neoantigen cancer vaccines), including autologous and allogeneic adoptive cell therapies (CAR-T, TCR, TIL, NK cells). Today, Andy identifies and implements innovative tools, datasets, and services that can impact clinical trial execution including quality, patient diversity, site identification, and trial timelines.
-
Read: Breast Cancer Clinical Research Trends According to Citeline Data (JAN 2017–OCT 2022) -
Read: Current Trends in Cell Therapy According to Citeline Data (JAN 2017–AUG 2022) Clinical Trials - Cell Therapies
Current Trends in Cell Therapy According to Citeline Data (JAN 2017–AUG 2022)
| -
Read: Current Trends in Gene Therapy According to Citeline Data (JAN 2017–AUG 2022) Clinical Trials - Gene Therapies
Current Trends in Gene Therapy According to Citeline Data (JAN 2017–AUG 2022)
| -
Read: Technologies Advancing Patient Identification, Site Selection and Clinical Trial Recruitment Clinical Trials - Early Phase Research
Technologies Advancing Patient Identification, Site Selection and Clinical Trial Recruitment
| -
Read: Decentralized trial strategies and their impact in rare disease studies Clinical Trials - Rare Diseases
Decentralized trial strategies and their impact in rare disease studies
|